Boyer MJ - Search Results

1

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.

Lin HM, Castillo L, Mahon KL, Chiam K, Lee BY, Nguyen Q, Boyer MJ, Stockler MR, Pavlakis N, Marx G, Mallesara G, Gurney H, Clark SJ, Swarbrick A, Daly RJ, Horvath LG. Lin HM, et al. Among authors: boyer mj. Br J Cancer. 2014 May 13;110(10):2462-71. doi: 10.1038/bjc.2014.181. Epub 2014 Apr 8. Br J Cancer. 2014. PMID: 24714754 Free PMC article.

2

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Toner GC, Stockler MR, Boyer MJ, Jones M, Thomson DB, Harvey VJ, Olver IN, Dhillon H, McMullen A, Gebski VJ, Levi JA, Simes RJ. Toner GC, et al. Among authors: boyer mj. Lancet. 2001 Mar 10;357(9258):739-45. doi: 10.1016/s0140-6736(00)04165-9. Lancet. 2001. PMID: 11253966 Clinical Trial.

3

Testicular cancer management.

Boyer MJ, Stockler MR. Boyer MJ, et al. Med J Aust. 2001 Apr 2;174(7):320-1. doi: 10.5694/j.1326-5377.2001.tb143301.x. Med J Aust. 2001. PMID: 11346099 No abstract available.

4

Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.

Horvath LG, McCaughan BC, Stockle M, Boyer MJ. Horvath LG, et al. Among authors: boyer mj. Intern Med J. 2002 Mar;32(3):79-83. Intern Med J. 2002. PMID: 11885847

5

Prolonged survival after the diagnosis of metastatic hepatic epitheliod haemangioendothelioma.

Joshua AM, Stockler MR, Boyer MJ. Joshua AM, et al. Among authors: boyer mj. Intern Med J. 2004 Jan-Feb;34(1-2):70-1. doi: 10.1111/j.1444-0903.2004.00514.x. Intern Med J. 2004. PMID: 14748919 No abstract available.

6

Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer.

Joshua AM, Nordman I, Venkataswaran R, Clarke S, Stockler MR, Boyer MJ. Joshua AM, et al. Among authors: boyer mj. Intern Med J. 2005 Aug;35(8):468-72. doi: 10.1111/j.1445-5994.2005.00883.x. Intern Med J. 2005. PMID: 16176469 Clinical Trial.

7

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.

Stockler MR, Tattersall MH, Boyer MJ, Clarke SJ, Beale PJ, Simes RJ. Stockler MR, et al. Among authors: boyer mj. Br J Cancer. 2006 Jan 30;94(2):208-12. doi: 10.1038/sj.bjc.6602908. Br J Cancer. 2006. PMID: 16404420 Free PMC article.

8

Predicting the toxicity of weekly docetaxel in advanced cancer.

Charles KA, Rivory LP, Stockler MR, Beale P, Beith J, Boyer M, Clarke SJ. Charles KA, et al. Clin Pharmacokinet. 2006;45(6):611-22. doi: 10.2165/00003088-200645060-00004. Clin Pharmacokinet. 2006. PMID: 16719542 Clinical Trial.

9

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.

Pezaro C, Rosenthal MA, Gurney H, Davis ID, Underhill C, Boyer MJ, Kotasek D, Solomon B, Toner GC. Pezaro C, et al. Among authors: boyer mj. Am J Clin Oncol. 2009 Aug;32(4):338-41. doi: 10.1097/COC.0b013e31818b946b. Am J Clin Oncol. 2009. PMID: 19363437 Clinical Trial.

10

Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials.

Soon YY, Stockler MR, Askie LM, Boyer MJ. Soon YY, et al. Among authors: boyer mj. J Clin Oncol. 2009 Jul 10;27(20):3277-83. doi: 10.1200/JCO.2008.19.4522. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters